Lilly Buys Psychedelics Maker Atai Beckley for $2.8B
Eli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
Identify index funds that offer best value for retirement by comparing costs, diversification, and potential returns, with practical fund picks.
27,007 articlesEli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
Nio is signaling a major profitability milestone with its first adjusted profit, but the real impact for investors de...
When headlines shout about quantum computing stock plummeting, it can feel like a nerve-wracking moment for investors...
Oracle defies the mood of a bruised AI rally, with Jefferies sticking to a buy and highlighting accelerating cloud gr...
Webull rolled out a March 2026 cash-bonuses program, offering tiered deposit matches and a first-transfer reimburseme...
Grayscale Research outlines a bull case for AAVE, arguing regulatory clarity could push its fair value toward $175 wi...
Billionaire investor Mark Cuban warns popular bets could quietly erode wealth as funding costs rise and consumer conf...
A global race to control a nascent $320 billion brain-implant market pits Elon Musk and Sam Altman against Chinese ri...
Global defense markets are shifting as high-tech anti-armor systems change battlefield economics. Investors are watch...
A major defense modernization program in Greece, nicknamed the Achilles Shield, signals long-term military procuremen...
In 2026, corporate bond spreads tightening is reshaping risk and return for the iShares LQD ETF, as yields, credit qu...
As clean energy climbs, storage plays a pivotal role. This article breaks down why energy stock soaring today points ...